Mervyn J Eadie1. 1. University of Queensland, and Royal Brisbane and Women's Hospital, Herston, Brisbane, Australia 4029, Australia. M.Eadie@uq.edu.au
Abstract
BACKGROUND: There is still uncertainty concerning the risk of fetal malformation associated with the intake of various individual antiepileptic drugs in pregnant women. OBJECTIVE: To assess the better-quality available evidence concerning the fetal hazards from exposure to antiepileptic drug monotherapy during human pregnancy. METHOD: Examination of the available English language literature, particularly that dealing with individual antiepileptic drugs used in monotherapy, in the larger case series with better-quality internal comparison data. CONCLUSIONS: There is reasonable evidence that valproate is a significant teratogen during therapeutic use in women; the other older antiepileptic drugs (phenobarbitone, phenytoin, carbamazepine) probably have some teratogenic potential, but less than valproate; the situation regarding the more recently marketed antiepileptic drugs is not yet clear.
BACKGROUND: There is still uncertainty concerning the risk of fetal malformation associated with the intake of various individual antiepileptic drugs in pregnant women. OBJECTIVE: To assess the better-quality available evidence concerning the fetal hazards from exposure to antiepileptic drug monotherapy during human pregnancy. METHOD: Examination of the available English language literature, particularly that dealing with individual antiepileptic drugs used in monotherapy, in the larger case series with better-quality internal comparison data. CONCLUSIONS: There is reasonable evidence that valproate is a significant teratogen during therapeutic use in women; the other older antiepileptic drugs (phenobarbitone, phenytoin, carbamazepine) probably have some teratogenic potential, but less than valproate; the situation regarding the more recently marketed antiepileptic drugs is not yet clear.
Authors: Linda de Jonge; Priscilla A Zetstra-van der Woude; H Jens Bos; Lolkje T W de Jong-van den Berg; Marian K Bakker Journal: Drug Saf Date: 2013-11 Impact factor: 5.606
Authors: Sarah J White; Howard P Hendrickson; William T Atchley; Elizabeth M Laurenzana; W Brooks Gentry; D Keith Williams; S Michael Owens Journal: Drug Metab Dispos Date: 2014-05-19 Impact factor: 3.922
Authors: Dileep K Rohra; Nirmal Das; Syed I Azam; Nazir A Solangi; Zahida Memon; Abdul M Shaikh; Nusrat H Khan Journal: BMC Pregnancy Childbirth Date: 2008-07-15 Impact factor: 3.007